A Randomised, Double-Blind, Placebo-Controlled, Single Ascending Dose and Multiple Dose Phase I Study to Assess the Safety, Pharmacokinetics and Effect of Food on Orally Administered DS102 in Healthy Subjects

Trial Profile

A Randomised, Double-Blind, Placebo-Controlled, Single Ascending Dose and Multiple Dose Phase I Study to Assess the Safety, Pharmacokinetics and Effect of Food on Orally Administered DS102 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Apr 2016

At a glance

  • Drugs DS 102 (Primary)
  • Indications Fibrosis; Non-alcoholic steatohepatitis
  • Focus Adverse reactions; First in man
  • Sponsors DS Biopharma
  • Most Recent Events

    • 14 Apr 2016 Results from this trial were presented at the annual meeting of the EASL International Liver Congress, according to a DS Biopharma media release.
    • 14 Apr 2016 Results published in a DS Biopharma media release.
    • 18 Dec 2015 Results published in a DS Biopharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top